Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney Cancer

Clinical trial NCT07716735 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07716735
Sponsor: Jonsson Comprehensive Cancer Center
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Kidney Carcinoma Advanced Renal Cell Carcinoma Hereditary Leiomyomatosis and Renal Cell Carcinoma Metastatic Kidney Carcinoma Metastatic Renal Cell Carcinoma Skin Leiomyoma Stage III Renal Cell Cancer AJCC v8 Stage IV Renal Cell Cancer AJCC v8 Uterine Corpus Leiomyoma

Start date: 2026-12-01
Primary completion: 2034-12-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.